Search

Author/Creator Sonneveld, P.

1. DARATUMUMAB, BORTEZOMIB AND DEXAMETHASONE (DVD) VS BORTEZOMIB AND DEXAMETHASONE (VD) IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM): EFFICACY AND SAFETY UPDATE (CASTOR). (June 2017)

Authors:
Lentzsch, S.; Weisel, K.; Mateos, M.V.; Hungria, V.; Munder, M.; Nooka, A.; Mark, T.; Quach, H.; Scott, E.; Lee, J.; Sonneveld, P.; Casneuf, T.; Chiu, C.; Qin, X.; Amin, H.; Thiyagarajah, P.; Schecter, J.; Qi, M.; Spencer, A.
Journal:
Hematological oncology
Issue:
Volume 35(2017)Supplement 2
Page Start:
388
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. OC-10 - Disseminated intravascular coagulation at diagnosis strongly predicts both arterial and venous thrombosis in acute myeloid leukemia patients. Issue 140 (April 2016)

Authors:
Libourel, E.J.; Klerk, C.; van Norden, Y.; de Maat, M.P.M.; Kruip, M.J.; Sonneveld, P.; Löwenberg, B.; Leebeek, F.W.G.
Journal:
Thrombosis research
Issue:
Issue 140(2016)Supplement 1
Page Start:
S172
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. P1714: HEALTHCARE RESOURCE UTILIZATION IN PATIENTS WITH LIGHT CHAIN AMYLOIDOSIS IN EUROPE. (23rd June 2022)

Authors:
Jaccard, A.; Bridoux, F.; Roeloffzen, W.; Minnema, M. C.; Bergantim, R.; Hájek, R.; João, C.; Cibeira, M. T.; Palladini, G.; Schönland, S.; Merlini, G.; Milani, P.; Dimopoulos, M. A.; Ravichandran, S.; Hegenbart, U.; Agis, H.; Gros, B.; Asra, A.; Dergarabetian, E.; Magarotto, V.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
1595
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. P905: IXAZOMIB-THALIDOMIDE-DEXAMETHASONE INDUCTION FOLLOWED BY IXAZOMIB OR PLACEBO MAINTENANCE IN NON-TRANSPLANT ELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS; LONG-TERM RESULTS OF HOVON-126/NMSG 21.13. (23rd June 2022)

Authors:
Groen, K.; Seefat, M. R.; van der Holt, B.; Schjesvold, F. H.; Stege, C. A.; Levin, M.-D.; Hansson, M.; Leys, R. B.; Regelink, J.; Waage, A.; Szatkowski, D.; Axelsson, P.; Do, T. H.; Svirskaite, A.; van der Spek, E.; Haukas, E.; Knut-Bojanowska, D.; Ypma, P. F.; Blimark, C.; Mellqvist, U.-H.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
796
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. P906: IXAZOMIB, DARATUMUMAB AND LOW DOSE DEXAMETHASONE IN FRAIL PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): RESULTS OF THE MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY. (23rd June 2022)

Authors:
Groen, K.; Seefat, M.; Nasserinejad, K.; Stege, C. A.; van der Spek, E.; Bilgin, Y. M.; Kentos, A.; Sohne, M.; van Kampen, R. J.; Ludwig, I.; Thielen, N.; Durdu-Rayman, N.; de Graauw, N. C.; van de Donk, N. W.; de Waal, E. G.; Vekemans, M.-C.; Timmers, G. J.; van der Klift, M.; Soechit, S.; Geert...
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
797
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. P914: EFFICACY AND SAFETY OF BELANTAMAB MAFODOTIN MONOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY LIGHT CHAIN AMYLOIDOSIS: A PHASE 2 STUDY BY THE EUROPEAN MYELOMA NETWORK. (23rd June 2022)

Authors:
Kastritis, E.; Palladini, G.; Dimopoulos, M. A.; Jaccard, A.; Merlini, G.; Theodorakakou, F.; Fotiou, D.; Minnema, M. C.; Wechalekar, A.; Gkolfinopoulos, S.; Manousou, K.; Sonneveld, P.; Schönland, S.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
804
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. P915: EFFICACY AND SAFETY OF DARATUMUMAB MONOTHERAPY IN NEWLY DIAGNOSED PATIENTS WITH STAGE 3B LIGHT CHAIN AMYLOIDOSIS: A PHASE 2 STUDY BY THE EUROPEAN MYELOMA NETWORK. (23rd June 2022)

Authors:
Kastritis, E.; Minnema, M. C.; Dimopoulos, M. A.; Merlini, G.; Theodorakakou, F.; Fotiou, D.; Huart, A.; Belhadj, K.; Gkolfinopoulos, S.; Manousou, K.; Sonneveld, P.; Palladini, G.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
805
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. P933: DARATUMUMAB (D) IN COMBINATION WITH VD OR D-RD IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: SUBGROUP ANALYSIS OF CASTOR AND POLLUX STUDIES IN PATIENTS WITH EARLY OR LATE RELAPSE AFTER INITIAL THERAPY. (23rd June 2022)

Authors:
Spencer, A.; Moreau, P.; Mateos, M.-V.; Goldschmidt, H.; Suzuki, K.; Levin, M.-D.; Sonneveld, P.; Yoon, S.-S.; Usmani, S. Z.; Weisel, K.; Reece, D.; Ahmadi, T.; Pei, H.; Garvin Mayo, W.; Gai, X.; Carey, J.; Carson, R.; Dimopoulos, M. A.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
823
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial Hypertension. (8th April 2019)

Authors:
Bringhen, S.; Milan, A.; D'Agostino, M.; Ferri, C.; Wäsch, R.; Gay, F.; Larocca, A.; Offidani, M.; Zweegman, S.; Terpos, E.; Goldschmidt, H.; Cavo, M.; Ludwig, H.; Driessen, C.; Auner, H. W.; Caers, J.; Gramatzki, M.; Dimopoulos, M. A.; Boccadoro, M.; Einsele, H.
Journal:
Journal of internal medicine
Issue:
Volume 286:Number 1(2019)
Page Start:
63
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗